Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L, Sesé M, Cánovas V, Punyal Y, Fernández Y, Abasolo I, de Torres I, Ruiz C, Espinosa L, Bigas A, Y Cajal SR, Fernández PL, Serras F, Corominas M, Thomson TM, Paciucci R. Alaña L, et al. Among authors: canovas v. Mol Cancer. 2014 Mar 31;13:74. doi: 10.1186/1476-4598-13-74. Mol Cancer. 2014. PMID: 24684754 Free PMC article.
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mateo F, Meca-Cortés O, Celià-Terrassa T, Fernández Y, Abasolo I, Sánchez-Cid L, Bermudo R, Sagasta A, Rodríguez-Carunchio L, Pons M, Cánovas V, Marín-Aguilera M, Mengual L, Alcaraz A, Schwartz S Jr, Mellado B, Aguilera KY, Brekken R, Fernández PL, Paciucci R, Thomson TM. Mateo F, et al. Among authors: canovas v. Mol Cancer. 2014 Oct 21;13:237. doi: 10.1186/1476-4598-13-237. Mol Cancer. 2014. PMID: 25331979 Free PMC article.
Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1.
Marqués N, Sesé M, Cánovas V, Valente F, Bermudo R, de Torres I, Fernández Y, Abasolo I, Fernández PL, Contreras H, Castellón E, Celià-Terrassa T, Méndez R, Ramón Y Cajal S, Thomson TM, Paciucci R. Marqués N, et al. Among authors: canovas v. Oncogene. 2014 Feb 27;33(9):1124-34. doi: 10.1038/onc.2013.51. Epub 2013 Mar 4. Oncogene. 2014. PMID: 23455324
Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature.
Lecumberri R, Krsnik I, Askari E, Sirvent M, González-Pérez MS, Escalante F, Pradillo V, Tamariz LE, Cánovas V, Alegre A, Gironella M, González-García ME, Infante MS, Lakhwani S, Martínez-Bilbao C, Dourdil V, Ramírez-Payer Á, Sarrá J, Cibeira MT. Lecumberri R, et al. Among authors: canovas v. Amyloid. 2020 Sep;27(3):163-167. doi: 10.1080/13506129.2020.1730791. Epub 2020 Feb 28. Amyloid. 2020. PMID: 32106714 Clinical Trial.
Haloarchaea as Cell Factories to Produce Bioplastics.
Simó-Cabrera L, García-Chumillas S, Hagagy N, Saddiq A, Tag H, Selim S, AbdElgawad H, Arribas Agüero A, Monzó Sánchez F, Cánovas V, Pire C, Martínez-Espinosa RM. Simó-Cabrera L, et al. Among authors: canovas v. Mar Drugs. 2021 Mar 18;19(3):159. doi: 10.3390/md19030159. Mar Drugs. 2021. PMID: 33803653 Free PMC article. Review.
Multiple bone lesions resembling a metastatic origin. An unexpected diagnosis.
Molina-Garrido MJ, Mora A, Andrada E, Guillén-Ponce C, Cánovas V, Guirado-Risueño M, Pastor E, Molina MA, Molina MJ, Martín Hidalgo A, Carrato A. Molina-Garrido MJ, et al. Among authors: canovas v. Clin Transl Oncol. 2008 Apr;10(4):241-5. doi: 10.1007/s12094-008-0190-0. Clin Transl Oncol. 2008. PMID: 18411200
11 results